Jun 26, 2017 10:33 am UTC| Business
SYDNEY, Australia, June 26, 2017 -- Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD), has provided an update on the Company’s two active clinical trials in IMP321. Prima is pleased to advise that clinical studies of IMP321 are...
Jun 26, 2017 10:30 am UTC| Business
BRUSSELS, Belgium, June 26, 2017 -- WABCO Holdings Inc. (NYSE:WBC) (www.wabco-auto.com), a leading global supplier of technologies and services that improve the safety, efficiency and connectivity of commercial...
Epizyme Expands Clinical Collaboration to Study Tazemetostat and TECENTRIQ® Combination in NSCLC
Jun 26, 2017 10:30 am UTC| Business
Tazemetostat and Atezolizumab to be Evaluated as New Combination in Study of Non-Small Cell Lung Cancer as Part of Genentech’s MORPHEUS Cancer Immunotherapy Platform Further Expands Tazemetostat Solid Tumor Program ...
Medical/Hospital Beds Market, 2021
Jun 26, 2017 10:21 am UTC| Business
Dublin, June 26, 2017 -- Research and Markets has announced the addition of the "Global Medical/Hospital Beds Market Outlook: 2016-2021" report to their offering. The global hospital...
Jun 26, 2017 10:16 am UTC| Business
Dublin, June 26, 2017 -- Research and Markets has announced the addition of the "Nano-Enabled Batteries - Global Strategic Business Report" report to their offering. This report...
Jun 26, 2017 10:10 am UTC| Business
Dublin, June 26, 2017 -- Research and Markets has announced the addition of the "Electronic Bill Presentment and Payment (EBPP) - Global Strategic Business Report" report to their offering. ...
Jun 26, 2017 10:05 am UTC| Business
BEDMINSTER, N.J., June 26, 2017 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, today reported...